HomeCompareKDGTF vs VIG

KDGTF vs VIG: Dividend Comparison 2026

KDGTF yields 292.70% · VIG yields 1.61%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KDGTF wins by $1283.51M in total portfolio value
10 years
KDGTF
KDGTF
● Live price
292.70%
Share price
$0.68
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1283.54M
Annual income
$767,632,391.00
Full KDGTF calculator →
VIG
Vanguard Dividend Appreciation ETF
● Live price
1.61%
Share price
$215.06
Annual div
$3.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.3K
Annual income
$175.21
Full VIG calculator →

Portfolio growth — KDGTF vs VIG

📍 KDGTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKDGTFVIG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KDGTF + VIG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KDGTF pays
VIG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KDGTF
Annual income on $10K today (after 15% tax)
$24,879.26/yr
After 10yr DRIP, annual income (after tax)
$652,487,532.35/yr
VIG
Annual income on $10K today (after 15% tax)
$136.50/yr
After 10yr DRIP, annual income (after tax)
$148.93/yr
At 15% tax rate, KDGTF beats the other by $652,487,383.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KDGTF + VIG for your $10,000?

KDGTF: 50%VIG: 50%
100% VIG50/50100% KDGTF
Portfolio after 10yr
$641.79M
Annual income
$383,816,283.10/yr
Blended yield
59.80%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KDGTF buys
0
VIG buys
9
PoliticianChamberTickerTypeAmountDate
Thomas R. Carper🏛 Senate$VIG▲ Buy$1,001 - $15,0002024-05-16
Lindsey Graham🏛 Senate$VIG▼ Sell$15,001 - $50,0002024-01-26
Lindsey Graham🏛 Senate$VIG▼ Sell$15,001 - $50,0002024-01-26
Lindsey Graham🏛 Senate$VIG▼ Sell$15,001 - $50,0002023-12-28
Ro Khanna🏢 House$VIG▼ Sell$15,001 - $50,0002023-05-04
K. Michael Conaway🏢 House$VIG▲ Buy$50,001 - $100,0002020-12-10
K. Michael Conaway🏢 House$VIG▲ Buy$50,001 - $100,0002020-12-10
Joe Courtney🏢 House$VIG▼ Sell$1,001 - $15,0002020-10-09
K. Michael Conaway🏢 House$VIG▼ Sell$50,001 - $100,0002020-09-08
K. Michael Conaway🏢 House$VIG▲ Buy$15,001 - $50,0002020-05-19
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKDGTFVIG
Forward yield292.70%1.61%
Annual dividend / share$2.00$3.45
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1283.54M$32.3K
Annual income after 10y$767,632,391.00$175.21
Total dividends collected$1231.38M$1.7K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: KDGTF vs VIG ($10,000, DRIP)

YearKDGTF PortfolioKDGTF Income/yrVIG PortfolioVIG Income/yrGap
1← crossover$39,970$29,269.72$11,301$160.59+$28.7KKDGTF
2$152,104$109,336.69$12,752$162.91+$139.4KKDGTF
3$551,611$388,859.29$14,370$165.02+$537.2KKDGTF
4$1,908,177$1,317,953.42$16,176$166.93+$1.89MKDGTF
5$6,302,657$4,260,907.77$18,188$168.67+$6.28MKDGTF
6$19,896,799$13,152,956.21$20,432$170.25+$19.88MKDGTF
7$60,095,598$38,806,022.48$22,933$171.68+$60.07MKDGTF
8$173,842,808$109,540,518.26$25,720$172.98+$173.82MKDGTF
9$482,157,266$296,145,461.77$28,827$174.15+$482.13MKDGTF
10$1,283,540,666$767,632,391.00$32,288$175.21+$1283.51MKDGTF

KDGTF vs VIG: Complete Analysis 2026

KDGTFStock

Kindstar Globalgene Technology, Inc. provides esoteric testing services to hospitals in China. The company offers its esoteric testing services for clinical specialist physicians in hematologic tumor, rare diseases, diseases of obstetrics and gynecology, neurology, infectious diseases, solid tumors, etc. It provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules and evaluation for curative effect of specialized diseases. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and other esoteric testing laboratories. The company was founded in 2003 and is headquartered in in Wuhan, China.

Full KDGTF Calculator →

VIGETF

Seeks to track the performance of the S&P U.S. Dividend Growers Index.Passively managed, full-replication approach.Fund remains fully invested.Large-cap equity, emphasizing stocks with a record of growing their dividends year over year.Low expenses minimize net tracking error.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full VIG Calculator →
📬

Get this KDGTF vs VIG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KDGTF vs SCHDKDGTF vs JEPIKDGTF vs OKDGTF vs KOKDGTF vs MAINKDGTF vs DGROKDGTF vs NOBLKDGTF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.